These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31177556)

  • 1. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.
    Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF;
    Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.
    Bertrand A; Wen J; Rinaldi D; Houot M; Sayah S; Camuzat A; Fournier C; Fontanella S; Routier A; Couratier P; Pasquier F; Habert MO; Hannequin D; Martinaud O; Caroppo P; Levy R; Dubois B; Brice A; Durrleman S; Colliot O; Le Ber I;
    JAMA Neurol; 2018 Feb; 75(2):236-245. PubMed ID: 29197216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficits in verbal fluency in presymptomatic
    Lulé DE; Müller HP; Finsel J; Weydt P; Knehr A; Winroth I; Andersen P; Weishaupt J; Uttner I; Kassubek J; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1195-1200. PubMed ID: 32855285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurite density is reduced in the presymptomatic phase of
    Wen J; Zhang H; Alexander DC; Durrleman S; Routier A; Rinaldi D; Houot M; Couratier P; Hannequin D; Pasquier F; Zhang J; Colliot O; Le Ber I; Bertrand A;
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):387-394. PubMed ID: 30355607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy.
    R K Roy A; Noohi F; Morris NA; Ljubenkov P; Heuer H; Fong J; Hall M; Lario Lago A; Rankin KP; Miller BL; Boxer AL; Rosen HJ; Seeley WW; Perry DC; Yokoyama JS; Lee SE; Sturm VE
    Neuroimage Clin; 2024; 43():103649. PubMed ID: 39098187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.
    Bede P; Lulé D; Müller HP; Tan EL; Dorst J; Ludolph AC; Kassubek J
    J Neurol; 2023 Sep; 270(9):4235-4247. PubMed ID: 37178170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.
    Feis RA; Bouts MJRJ; Panman JL; Jiskoot LC; Dopper EGP; Schouten TM; de Vos F; van der Grond J; van Swieten JC; Rombouts SARB
    Neuroimage Clin; 2018; 20():188-196. PubMed ID: 30094168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
    Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL
    Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression in
    Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
    Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomics of
    Bonham LW; Geier EG; Sirkis DW; Leong JK; Ramos EM; Wang Q; Karydas A; Lee SE; Sturm VE; Sawyer RP; Friedberg A; Ichida JK; Gitler AD; Sugrue L; Cordingley M; Bee W; Weber E; Kramer JH; Rankin KP; Rosen HJ; Boxer AL; Seeley WW; Ravits J; Miller BL; Yokoyama JS
    J Neurosci; 2023 Jan; 43(2):333-345. PubMed ID: 36446586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study.
    Bede P; Omer T; Finegan E; Chipika RH; Iyer PM; Doherty MA; Vajda A; Pender N; McLaughlin RL; Hutchinson S; Hardiman O
    Brain Imaging Behav; 2018 Dec; 12(6):1696-1707. PubMed ID: 29423814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal diffusion imaging across the
    Floeter MK; Danielian LE; Braun LE; Wu T
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):53-60. PubMed ID: 29054917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer).
    Rasoanandrianina H; Grapperon AM; Taso M; Girard OM; Duhamel G; Guye M; Ranjeva JP; Attarian S; Verschueren A; Callot V
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28926131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.
    van der Geest AT; Jakobs CE; Ljubikj T; Huffels CFM; Cañizares Luna M; Vieira de Sá R; Adolfs Y; de Wit M; Rutten DH; Kaal M; Zwartkruis MM; Carcolé M; Groen EJN; Hol EM; Basak O; Isaacs AM; Westeneng HJ; van den Berg LH; Veldink JH; Schlegel DK; Pasterkamp RJ
    Acta Neuropathol Commun; 2024 Sep; 12(1):152. PubMed ID: 39289761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.
    Olm CA; McMillan CT; Irwin DJ; Van Deerlin VM; Cook PA; Gee JC; Grossman M
    Neuroimage Clin; 2018; 19():497-506. PubMed ID: 29984158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.